UKTN | The Podcast podcast

Producing drugs in outer space – Katie King, BioOrbit

0:00
30:18
Reculer de 15 secondes
Avancer de 15 secondes

Katie King, co-founder and chief executive of BioOrbit, discusses how her company is building pharmaceutical manufacturing facilities designed to operate in space and why that could fundamentally transform how the production of medicine works. 

BioOrbit is a British space tech company that aims to use the irreplicable conditions of outer space to improve the development of drugs that could massively shape how humans treat some of Earth’s most dangerous conditions. 

D'autres épisodes de "UKTN | The Podcast"